Sarizotan

Unassigned

New Medicines

Rett syndrome with respiratory symptoms

Information

New molecular entity
Newron
Newron

Development and Regulatory status

Discontinued
Discontinued
Discontinued
Yes
Yes
May 20 · Following negative efficacy results in STARS study, Newron has decided to terminate this development program [8]

Category

A serotonin (5-HT)1A receptor agonist and a partial agonist/antagonist at D2 receptor
Rett syndrome (RTT) is a severe neurodevelopmental disorder affecting the central nervous system. EU prevalence is 1-9 per 100,000 people [1].
Rett syndrome with respiratory symptoms
Oral

Further information

Yes

Evidence based evaluations